Abstract
IntroductionOver 265 000 women are living with HIV in the USA, but limited research has investigated the physical, mental and behavioural health outcomes among women living with HIV of reproductive age. Health status during the reproductive years before, during and after pregnancy affects pregnancy outcomes and long-term health. Understanding health outcomes among women living with HIV of reproductive age is of substantial public health importance, regardless of whether they experience pregnancy. The Health Outcomes around Pregnancy and Exposure to HIV/Antiretrovirals (HOPE) study is a prospective observational cohort study designed to investigate physical and mental health outcomes of young women living with HIV as they age, including HIV disease course, engagement in care, reproductive health and choices and cardiometabolic health. We describe the HOPE study design, and characteristics of the first 437 participants enrolled as of 1 January 2024.Methods and analysisThe HOPE study seeks to enrol and follow 1630 women living with HIV of reproductive age, including those with perinatally-acquired HIV, at 12 clinical sites across 9 US states and Puerto Rico. HOPE studies multilevel dynamic determinants influencing physical, mental and social well-being and behaviours of women living with HIV across the reproductive life course (preconception, pregnancy, post partum, not or never-pregnant), informed by the socioecological model. Key research areas include the clinical course of HIV, relationship of HIV and antiretroviral medications to reproductive health, pregnancy outcomes and comorbidities and the influence of racism and social determinants of health. HOPE began enrolling in April 2022.Ethics and disseminationThe HOPE study received approval from the Harvard Longwood Campus Institutional Review Board, the single institutional review board of record for all HOPE sites. Results will be disseminated through conference presentations, peer-reviewed journals and lay summaries.
Funder
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Pediatric HIV/AIDS Cohort Study (PHACS) 2020
Reference97 articles.
1. World Health Organization . The Global Health Observatory: HIV/AIDS. 2022. Available: https://www.who.int/data/gho/data/themes/hiv-aids [Accessed 8 Apr 2023].
2. UNAIDS . Global HIV and AIDS Statistics – fact sheet. Available: https://www.unaids.org/en/resources/fact-sheet [Accessed 10 Aug 2023].
3. Centers for Disease Control and Prevention . Estimated HIV incidence and prevalence in the United States, 2017–2021. HIV Surveillance Supplemental Report; 2023. Available: https://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-28-no-3/index.html [Accessed 1 Jun 2023].
4. Cisgender women with HIV in the United States: how have HIV care continuum outcomes changed over time? 2015-2020;O’Shea;AIDS,2023
5. Centers for Disease Control and Prevention . Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas, 2021. HIV Surveillance Supplemental Report; 2023. Available: http://www.cdc.gov/hiv/library/reports/hiv-surveillance/vol-28-no-4/content/tables.html [Accessed 2 Jun 2023].